Valeant Coverage Plus Program

Eligible* patients will pay $0 or $25 for their monthly prescriptions for SYPRINE® (trientine hydrochloride)
Which Option Is Better for Me?

Patients with commercial insurance may want to consider the co-pay savings offer. Eligible patients will pay no more than $25 per month in out-of-pocket costs on their monthly prescription of SYPRINE®.

Patients with no prescription drug coverage may qualify for the Wilson Disease Patient Assistance Program (where eligible patients pay $0 in out-of-pocket costs on their monthly prescription of SYPRINE®). For more information, call a Coverage Plus representative at 888-607-7267.

If you are still unsure about which option may be best for you, call the Valeant Coverage Plus Program at 888-607-7267 Monday–Friday, 8:00 AM–6:00 PM ET.
Enrollment Is Easy
To get started, visit http://www.valeantcoverageplus.com, download the Valeant Coverage Plus Program (VCPP) Enrollment Form, and follow the simple steps below. The process is the same whether the patient is starting SYPRINE® for the first time or is currently on treatment.
1
 
DOWNLOAD AND COMPLETE THE ENROLLMENT FORM
The patient and doctor complete the appropriate sections on the enrollment form.
2
 
THE DOCTOR PRESCRIBES SYPRINE®
The doctor attaches a valid prescription to the enrollment form and has a choice of submitting to VCPP in one of two ways:
  • Faxing to 855-735-4624, or
  • Mailing to: Valeant Coverage Plus Program, PO Box 220667, Charlotte NC 28222-0667
3
 
VCPP GETS TO WORK
Your Valeant Coverage Plus representative:
  • Researches insurance coverage and determines which VCPP assistance options are right for the patient
  • Calls the patient to complete the enrollment
4
 
DELIVERY IS SCHEDULED
  • Medication is delivered to the patient's home
 

Information provided will always be kept confidential. Valeant offers the Coverage Plus program in compliance with patient privacy regulations (HIPAA).
Enrollment in the program is effective from the date of approval through the end of the calendar year (January 1 through December 31). VCPP will automatically conduct a benefits check to re-enroll patients in the program in the next calendar year unless they decide to opt out of the program or their insurance coverage changes.
The VCPP is sponsored by Valeant Pharmaceuticals North America LLC.
*Eligibility Requirements: This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare, Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. These patients may qualify for alternative financial assistance. For more information, call a Valeant Coverage Plus representative at 888-607-7267.
All patients must be legal US residents and be treated by a US provider.
INDICATIONS AND USAGE
Syprine® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. Syprine is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis.
IMPORTANT SAFETY INFORMATION
  • Do not take Syprine if you are allergic to it or any parts of the formulation.
  • You should remain under regular medical supervision the entire time you are taking Syprine. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women.
  • Take Syprine on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor.
  • Tell your doctor if you are pregnant, plan to become pregnant, or are nursing.
  • The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis.
  • Do not take mineral supplements because they may block the absorption of Syprine.
Please click here to see full Prescribing Information for Syprine Capsules.
You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

©2016 Valeant Pharmaceuticals North America LLC. All Rights Reserved. SYP.0024.USA.16

 

Indications and Usage

Syprine® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. Syprine is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis.

Important Safety Information

  • Do not take Syprine if you are allergic to it or any parts of the formulation.
  • You should remain under regular medical supervision the entire time you are taking Syprine. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women.
  • Take Syprine on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor.
  • Tell your doctor if you are pregnant, plan to become pregnant, or are nursing.
  • The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis.
  • Do not take mineral supplements because they may block the absorption of Syprine.
Please click here to see full Prescribing Information for Syprine Capsules.
 

INDICATIONS AND USAGE

Syprine® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. SYPRINE® is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis.

IMPORTANT SAFETY INFORMATION

  • Do not take Syprine if you are allergic to it or any parts of the formulation.
  • You should remain under regular medical supervision the entire time you are taking Syprine. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women.
  • Take Syprine on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor.
  • Tell your doctor if you are pregnant, plan to become pregnant, or are nursing.
  • The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis.
  • Do not take mineral supplements because they may block the absorption of Syprine.
Please click here to see full Prescribing Information for Syprine Capsules.